Actavis Laboratories, FL recalls
FDA enforcement reports naming Actavis Laboratories, FL, Inc. as the recalling firm.
- Recall reports
- 7
- Class I (serious)
- 0
- Most recent report
- Nov 9, 2016
- Nov 9, 2016Ramipril Capsules, USP, 1Drug · Actavis Laboratories, FL, Inc.Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.Class III
- Oct 21, 2015Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, Rx only, Ma…Drug · Actavis Laboratories, FL, Inc.Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.Class II
- Aug 12, 2015Desmopressin Acetate Tablets, 0Drug · Actavis Laboratories, FL, Inc.Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.Class III
- Apr 22, 2015Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90…Drug · Actavis Laboratories, FL, Inc.Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shellClass III
- Dec 3, 2014Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0Drug · Actavis Laboratories, FL, Inc.Failed Tablet/Capsule Specifications: Presence of split or broken tablets.Class II
- Oct 8, 2014Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0Drug · Actavis Laboratories, FL, Inc.Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Class II
- Oct 8, 2014Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0Drug · Actavis Laboratories, FL, Inc.Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Class II